Research on pain management, the treatment gap, and cellular therapy


There is much to discover about how cell therapy has the potential to close the treatment gap between pain management and major surgery. 

Our research on OA of the knee, part of a pivotal Phase III trial, makes this trial one of those farthest along the path to potential FDA approval. There is emerging cell therapy research around other chronic degenerative diseases such as diabetic foot ulcers. 

To learn more about the emerging body of research on cell therapy and regenerative medicine, download our white paper here. 

Our cell therapy is investigational. It is not approved by the FDA for sale or use in the US.